PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP

Bibliographic Details
Main Authors:	K. Filonenko, I. Kriachok, A. Martynchyk, I. Titorenko, Y. Stepanishyna, O. Aleksyk, K. Ukianchenko, I. Pastushenko, Y. Kushchevyy, O. Novosad, O. Karnabeda, I. Diagil, V. Kozlov
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851288.96490.f9

Similar Items

PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA
by: O. Novosad, et al.
Published: (2022-06-01)

2114
by: Jennifer Knudtson, et al.
Published: (2017-09-01)

PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS
by: I. Tytorenko, et al.
Published: (2022-06-01)

PB2125: VCD VERSUS VRD‐BASED REGIMENS AS INDUCTION THERAPIES IN PATIENTS WITH PRIMARY MULTIPLE MYELOMA (MM): HIGHLIGHTING STRATEGIES THAT ACTUALLY WORK.
by: Olga Novosad, et al.
Published: (2023-08-01)

PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE
by: Malin Hultcrantz, et al.
Published: (2023-08-01)

PB2093: DIFFUSE LARGE B CELL LYMPHOMA IN THE ELDERLY
by: G. Abichou, et al.
Published: (2022-06-01)

PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS.
by: Z. Stupakova, et al.
Published: (2022-06-01)

Efficiency of NZ2114 on Superficial Pyoderma Infected with <i>Staphylococcus pseudintermedius</i>
by: Na Yang, et al.
Published: (2024-02-01)

PB2095: RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: EXPERIENCE OF A LOW-INCOME CENTER IN TIME OF NEW DRUGS
by: M. Charfi, et al.
Published: (2022-06-01)

PB2162: INCREASED OXIDATIVE STRESS IN DIFFUSE LARGE B-CELL LYMPHOMA
by: D. Antic, et al.
Published: (2022-06-01)

Whole-body diffusion-weighted magnetic resonance imaging by estimating the measurable diffusion coefficient in Hodgkin lymphoma
by: A. I. Mikhaylov, et al.
Published: (2016-02-01)

PB2092: PRIMARY BONE DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
by: G. Abichou, et al.
Published: (2022-06-01)

PB2135: BURKITT LYMPHOMA INTERNATIONAL PROGNOSTIC INDEX (BL-IPI): IS IT EFFICIENT ENOUGH IN ADULT BURKITT LYMPHOMA PATIENTS?
by: B. Sayinalp, et al.
Published: (2022-06-01)

Polylactic Glycolic Acid-Mediated Delivery of Plectasin Derivative NZ2114 in <i>Staphylococcus epidermidis</i> Biofilms
by: Xuanxuan Ma, et al.
Published: (2024-02-01)

In Vitro/Vivo Mechanisms of Antibacterial Peptide NZ2114 against <i>Staphylococcus pseudintermedius</i> and Its Biofilms
by: Shuang Zhang, et al.
Published: (2024-04-01)

2114 Temporal stability of the background velocity error shows potential for automated correction of regurgitant and shunt flow measurements
by: Pennell Dudley J, et al.
Published: (2008-10-01)

2114 Severity of childhood-onset systemic lupus erythematosus: Impact of preceding and co-existing autoimmune cytopenias (protocol)
by: Ekemini Akan, et al.
Published: (2018-06-01)

PB2064: RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH RADIOTHERAPY
by: F. Kallel, et al.
Published: (2022-06-01)

Cumulative incidence of hematological neoplasms and dynamic of this in different regions of the Cherkasy oblast in 1980, 1989, 2001 and 2014 years
by: V.V. Paramonov, et al.
Published: (2019-08-01)

PB2152: BIOLOGICAL AND CLINICAL CORRELATES OF GALECTIN-3 (GAL-3) EXPRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
by: S. Basic-Kinda, et al.
Published: (2022-06-01)

Massive Upper Gastrointestinal Bleeding Caused by Diffuse Large B-Cell Lymphoma
by: O. Telci Caklili, et al.
Published: (2016-01-01)

S222: MATURE T AND NK CELL LYMPHOMAS CLASSIFIED ACCORDING TO 2016 WHO CLASSIFICATION. A REPORT OF THE INTERNATIONAL PROSPECTIVE T-CELL PROJECT 2.0.
by: M. Federico, et al.
Published: (2022-06-01)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
by: R. Alonso Alonso, et al.
Published: (2022-06-01)

Impact Analysis of Super Typhoon 2114 ‘Chanthu’ on the Air Quality of Coastal Cities in Southeast China Based on Multi-Source Measurements
by: Fei Li, et al.
Published: (2023-02-01)

PB2129: COULD LYMPHOPENIA PREDICT OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA?
by: B. Merchan Muñoz, et al.
Published: (2022-06-01)

P1181: REAL-LIFE TREATMENT APPROACHES AND THERAPY RESULTS IN THE PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA: POLISH-UKRAINIAN EXPERIENCE
by: Kateryna Filonenko, et al.
Published: (2023-08-01)

Three in One with Dual-Functional Hydrogel of Lactoferrin/NZ2114/LMSH Promoting <i>Staphylococcus aureus</i>-Infected Wound Healing
by: Kun Zhang, et al.
Published: (2024-09-01)

Microstructural characterization data of as received IG-110, 2114 and ETU-10 nuclear graphite grades and oxidation characterization data of IG-110
by: José David Arregui-Mena, et al.
Published: (2022-10-01)

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA
by: Oksana Karnabeda, et al.
Published: (2023-08-01)

PB2169: METHYLATION OF P53-RESPONSIVE ONCOSUPPRESSIVE MICRORNA GENES IN DIFFUSE LARGE B-CELL LYMPHOMA TUMOR TISSUE
by: E. Voropaeva, et al.
Published: (2022-06-01)

EPIDEMIOLOGY AND CLINICO-DEMOGRAPHIC CHARACTERISTICS OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE NOVOSIBIRSK CITY
by: E. N. Voropaeva, et al.
Published: (2021-03-01)

PB2104: DOSE-DENSE CHEMOTHERAPY WITH R-CHOP-14 IN OLDER ADULTS AGED ≥80 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA
by: K. Christofyllakis, et al.
Published: (2022-06-01)

MicroRNAs implicated in canine diffuse large B‐cell lymphoma prognosis
by: Nelly O. Elshafie, et al.
Published: (2024-11-01)

miRNome expression analysis in canine diffuse large B-cell lymphoma
by: Nelly O. Elshafie, et al.
Published: (2023-08-01)

MUDFLOW CONTROL MEASURES AND EFFECTIVENESS OF THEIR APPLICATION IN THE BLACK SEA BASINS
by: Alexander I. Titorenko
Published: (2011-07-01)

PB2108: PREVALENCE AND CLINICAL IMPLICATIONS OF CYCLIN D1 POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA
by: X. Liang, et al.
Published: (2022-06-01)

PB2327: IS THERE ANY VALUE OF GERIATRIC INDICES IN DIFFUSE LARGE B CELL LYMPHOMA OF THE ELDERLY?
by: Dora Dragčević, et al.
Published: (2023-08-01)

PB2313: THE PROGNOSTIC SIGNIFICANCE OF APOPTOSIS-INDUCING FACTOR IN DIFFUSE LARGE B-CELL LYMPHOMA
by: Elena Vaneeva, et al.
Published: (2023-08-01)

PB2063: CHARACTERISTICS AND THERAPEUTIC RESULTS OF PATIENTS WITH REFRACTORY/RELAPSED HODGKIN LYMPHOMA IN A TUNISIAN CENTER
by: F. Kammoun, et al.
Published: (2022-06-01)

PB2156: ANALYSIS OF POSSIBLE CLONAL ORIGIN OF LARGE B-CELL DIFFUSED LYMPHOMAS ARISING IN PATIENTS WITH PRE-EXISTING HODGKIN’S LYMPHOMA
by: P. Masciopinto, et al.
Published: (2022-06-01)